Clinical Trial

A Study of Eloralintide (LY3841136) in Healthy Participants

Name: A Study of Eloralintide (LY3841136) in Healthy Participants — clinical trial record (NCT07701083)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main purpose of this study is to learn about safety, tolerability and how well the body processes two different eloralintide solutions. Participation in this study will last about 13 weeks, including screening, inpatient treatment, and follow-up.

Trial Details

NCT Number	NCT07701083
Lead Sponsor	Eli Lilly and Company
Conditions	Healthy Volunteers
Enrollment	58 participants
Start Date	2026-07
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-14